SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
Por:
Martin, A, Diaz, E, Escobar, I, Montero, R, Martinez-Marin, V, Olmos, V, Segura, P, Verduguez, T and Fernandez, M
Publicada:
1 feb 2020
Ahead of Print:
1 ene 2020
Resumen:
In 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in 2014, and since then, multiple studies and clinical trials have changed the landscape of the treatment and prophylaxis of VTE in cancer patients. To incorporate the most recent evidence, including data from direct oral anticoagulants (DOACs) randomized clinical trials, SEOM presents a new update of the guideline.
Filiaciones:
Martin, A:
Inst Invest Sanitaria Gregorio Maranon, Med Oncol Dept, C Dr Esquerdo 46, Madrid 28007, Spain
Diaz, E:
Univ Autonoma Barcelona, Med Oncol Dept, Parc Tauli Hosp Univ, I3PT, Sabadell, Spain
Escobar, I:
Hosp Gen Univ Ciudad Real, Med Oncol Dept, Ciudad Real, Spain
Montero, R:
Complejo Hosp Univ, Med Oncol Dept, Badajoz, Spain
Martinez-Marin, V:
Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain
Olmos, V:
Hosp Univ Ramon y Cajal, Med Oncol Dept, CIBERONC, IRYCIS, Madrid, Spain
Segura, P:
Hosp Univ Clin San Carlos, Med Oncol Dept, Madrid, Spain
:
Hosp Gen Univ Elche, Med Oncol Dept, Elche, Elche, Spain
Fernandez, M:
Complejo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
hybrid
|